To date, numerous evidences have reported that deregulated expressions of GLUT1 and GLUT 3 are associated with malignancy of several cancer types [5] including pancreatic [6, 7], gastric [8, 9], colorectal [10, 11], uterine [12, 13], oral [14, 15], neuroblastic cancer [16] and malignant peritoneal mesothelioma [17], however, some studies depicted longer survival associated with GLUTs expression while others detected no correlation or poorer survival. This evidence concerns the gene SLC2A3 and cancer.